Jaffetilchin Investment Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $531K | Sell |
11,476
-672
| -6% | -$31.1K | 0.03% | 254 |
|
2025
Q1 | $741K | Sell |
12,148
-291
| -2% | -$17.7K | 0.05% | 203 |
|
2024
Q4 | $704K | Buy |
12,439
+2,131
| +21% | +$121K | 0.05% | 194 |
|
2024
Q3 | $533K | Buy |
10,308
+393
| +4% | +$20.3K | 0.04% | 214 |
|
2024
Q2 | $412K | Sell |
9,915
-350
| -3% | -$14.5K | 0.04% | 242 |
|
2024
Q1 | $557K | Buy |
10,265
+912
| +10% | +$49.5K | 0.05% | 197 |
|
2023
Q4 | $480K | Sell |
9,353
-8,350
| -47% | -$428K | 0.05% | 222 |
|
2023
Q3 | $1.03M | Sell |
17,703
-2,609
| -13% | -$151K | 0.11% | 112 |
|
2023
Q2 | $1.3M | Buy |
20,312
+384
| +2% | +$24.6K | 0.14% | 101 |
|
2023
Q1 | $1.38M | Buy |
19,928
+716
| +4% | +$49.6K | 0.16% | 107 |
|
2022
Q4 | $1.38M | Sell |
19,212
-421
| -2% | -$30.3K | 0.17% | 103 |
|
2022
Q3 | $1.4M | Buy |
19,633
+1,708
| +10% | +$121K | 0.18% | 80 |
|
2022
Q2 | $1.38M | Sell |
17,925
-197
| -1% | -$15.2K | 0.16% | 94 |
|
2022
Q1 | $1.38M | Buy |
18,122
+1,218
| +7% | +$93K | 0.16% | 88 |
|
2021
Q4 | $1.05M | Sell |
16,904
-2,312
| -12% | -$144K | 0.1% | 135 |
|
2021
Q3 | $1.14M | Buy |
19,216
+1,026
| +6% | +$60.7K | 0.12% | 118 |
|
2021
Q2 | $1.22M | Buy |
18,190
+6,183
| +51% | +$413K | 0.08% | 159 |
|
2021
Q1 | $758K | Buy |
+12,007
| New | +$758K | 0.09% | 154 |
|
2019
Q2 | – | Sell |
-4,264
| Closed | -$203K | – | 268 |
|
2019
Q1 | $203K | Buy |
4,264
+58
| +1% | +$2.76K | 0.05% | 274 |
|
2018
Q4 | $219K | Buy |
4,206
+70
| +2% | +$3.65K | 0.05% | 231 |
|
2018
Q3 | $257K | Buy |
+4,136
| New | +$257K | 0.05% | 249 |
|
2016
Q3 | – | Sell |
-10,128
| Closed | -$745K | – | 221 |
|
2016
Q2 | $745K | Buy |
+10,128
| New | +$745K | 0.23% | 63 |
|